» Articles » PMID: 34880495

Structure of Pathological TDP-43 Filaments from ALS with FTLD

Overview
Journal Nature
Specialty Science
Date 2021 Dec 9
PMID 34880495
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD). It is also common in other diseases, including Alzheimer's and Parkinson's. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282-360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.

Citing Articles

TDP-43 as a potential retinal biomarker for neurodegenerative diseases.

Glashutter M, Wijesinghe P, Matsubara J Front Neurosci. 2025; 19:1533045.

PMID: 40012679 PMC: 11861351. DOI: 10.3389/fnins.2025.1533045.


TDP-43 Aggregate Seeding Impairs Autoregulation and Causes TDP-43 Dysfunction.

Mamede L, Hu M, Titus A, Vaquer-Alicea J, French R, Diamond M bioRxiv. 2025; .

PMID: 39990366 PMC: 11844547. DOI: 10.1101/2025.02.11.637743.


The Regulation of TDP-43 Structure and Phase Transitions: A Review.

Liu Y, Xiang J, Gong H, Yu T, Gao M, Huang Y Protein J. 2025; .

PMID: 39987392 DOI: 10.1007/s10930-025-10261-0.


Small heat shock protein HSPB8 interacts with a pre-fibrillar TDP43 low complexity domain species to delay fibril formation.

Jami K, Farb D, Osumi K, Shafer C, Criscione S, Murray D bioRxiv. 2025; .

PMID: 39974920 PMC: 11838303. DOI: 10.1101/2025.01.28.635368.


Tracing TMEM106B fibril deposition in aging and Parkinson's disease with dementia brains.

Zhao W, Fan Y, Zhao Q, Fan Z, Zhao J, Yu W Life Med. 2025; 3(1):lnae011.

PMID: 39872397 PMC: 11749594. DOI: 10.1093/lifemedi/lnae011.


References
1.
Neumann M, Sampathu D, Kwong L, Truax A, Micsenyi M, Chou T . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314(5796):130-3. DOI: 10.1126/science.1134108. View

2.
Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351(3):602-11. DOI: 10.1016/j.bbrc.2006.10.093. View

3.
Cao Q, Boyer D, Sawaya M, Ge P, Eisenberg D . Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat Struct Mol Biol. 2019; 26(7):619-627. PMC: 7047951. DOI: 10.1038/s41594-019-0248-4. View

4.
Li Q, Babinchak W, Surewicz W . Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nat Commun. 2021; 12(1):1620. PMC: 7955110. DOI: 10.1038/s41467-021-21912-y. View

5.
Brettschneider J, Del Tredici K, Toledo J, Robinson J, Irwin D, Grossman M . Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013; 74(1):20-38. PMC: 3785076. DOI: 10.1002/ana.23937. View